United Therapeutics
UTHR
UTHR
320 hedge funds and large institutions have $3.27B invested in United Therapeutics in 2019 Q2 according to their latest regulatory filings, with 54 funds opening new positions, 94 increasing their positions, 131 reducing their positions, and 105 closing their positions.
New
Increased
Maintained
Reduced
Closed
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less call options, than puts
Call options by funds: $ | Put options by funds: $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
35% less capital invested
Capital invested by funds: $5.01B → $3.27B (-$1.74B)
49% less first-time investments, than exits
New positions opened: 54 | Existing positions closed: 105
57% less funds holding in top 10
Funds holding in top 10: 7 → 3 (-4)
Holders
320
Holding in Top 10
3
Calls
$27.3M
Puts
$34.7M
Top Buyers
| 1 | +$129M | |
| 2 | +$62.4M | |
| 3 | +$53.3M | |
| 4 |
Two Sigma Investments
New York
|
+$45.4M |
| 5 |
D.E. Shaw & Co
New York
|
+$43.6M |
Top Sellers
| 1 | -$105M | |
| 2 | -$48.6M | |
| 3 | -$44.6M | |
| 4 |
WCM
Wedge Capital Management
Charlotte,
North Carolina
|
-$39.3M |
| 5 |
BlackRock
New York
|
-$39.2M |